Stem Cell Innovations Inc. To Provide Research And Assay Services To Agennix. Tuesday, 2 Mar 2010 08:03am EST Stem Cell Innovations Inc. announced that the Company has signed a Master Services Agreement to provide research and assay services in support of Agennix's talactoferrin program. The assay utilizes SCLL's C3A human liver cell line. In addition to the talactoferrin assays, the Company will provide other research and cell culture services to Agennix.
But not a peep since. No share holder party or nothing... that was a joke... lets just start with answering the phones right.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.